Authors : Parnika P. Kadam; Dr. Lalita S. Nemade; Apeksha C. Rahate

Volume/Issue : Volume 10 - 2025, Issue 8 - August

Google Scholar : https://tinyurl.com/jm9wj398

Scribd : https://tinyurl.com/4bzccjny

DOI : https://doi.org/10.38124/ijisrt/25aug1258

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : This review examines the incorporation of bromelain, a proteolytic enzyme complex derived from pineapple, into advanced drug delivery systems. Bromelain has demonstrated anti-inflammatory, analgesic, fibrinolytic, and wound- healing properties, but its therapeutic use is limited by its poor stability and low bioavailability. The pharmacological profile, mechanisms of action, and conventional dosage forms of bromelain are also discussed. Advanced delivery approaches using nanocarriers, such as nanoparticles, liposomes, and nanoemulsions, have been explored as strategies to enhance the stability, bioavailability, and targeted delivery of bromelain. Clinical applications in areas such as anti- inflammatory therapy, wound healing, and cancer treatment are reviewed, along with challenges in translating nano- formulations to commercial products. The integration of bromelain into novel drug delivery platforms and combination therapies represents a promising strategy for expanding its therapeutic potential. Further research is needed to optimize these formulations and to demonstrate the clinical efficacy of advanced bromelain delivery systems.

Keywords : Bromelain, Drug Delivery Systems, Nanocarriers, Anti-Inflammatory, Proteolytic Enzyme, Pineapple-Derived Enzyme, Clinical Applications.

References :

1. A. A. Şahin, “Bromelain, a potential therapeutic compound from ananas comosus,” Lokman Hekim Health Sciences, 2021, doi: 10.14744/lhhs.2021.10001.
2. C. Varilla, M. Marcone, L. Paiva, and J. Baptista, “Bromelain, a Group of Pineapple Proteolytic Complex Enzymes (Ananas comosus) and Their Possible Therapeutic and Clinical Effects. A Summary,” Foods, vol. 10, no. 10, p. 2249, Sep. 2021, doi: 10.3390/foods10102249.
3. P. Hikisz and J. Bernasinska-Slomczewska, “Beneficial Properties of Bromelain,” Nutrients, vol. 13, no. 12, p. 4313, Nov. 2021, doi: 10.3390/nu13124313.
4. A. Chakraborty et al., “Bromelain a Potential Bioactive Compound: A Comprehensive Overview from a Pharmacological Perspective,” Life, vol. 11, no. 4, p. 317, Apr. 2021, doi: 10.3390/life11040317.
5. T. Alves Nobre et al., “Bromelain as a natural anti-inflammatory drug: a systematic review,” Nat Prod Res, vol. 39, no. 5, pp. 1258–1271, Mar. 2025, doi: 10.1080/14786419.2024.2342553.
6. G. Sharma and A. Vimal, “Bromelain: An Enzyme Expanding its Horizon from Food to Pharmaceutical Industry,” Curr Pharm Biotechnol, vol. 24, no. 14, pp. 1715–1726, Nov. 2023, doi: 10.2174/1389201024666230331115338.
7. R. Bottega, I. Persico, F. De Seta, F. Romano, and G. Di Lorenzo, “Anti-inflammatory properties of a proprietary bromelain extract (BromeyalTM) after in vitro simulated gastrointestinal digestion,” Int J Immunopathol Pharmacol, vol. 35, Jan. 2021, doi: 10.1177/20587384211034686.
8. M. Ebrahimian, F. Mahvelati, B. Malaekeh-Nikouei, E. Hashemi, F. Oroojalian, and M. Hashemi, “Bromelain Loaded Lipid-Polymer Hybrid Nanoparticles for Oral Delivery: Formulation and Characterization,” Appl Biochem Biotechnol, vol. 194, no. 8, pp. 3733–3748, Aug. 2022, doi: 10.1007/s12010-022-03812-z.
9. G. Chisci and L. Fredianelli, “Therapeutic Efficacy of Bromelain in Alveolar Ridge Preservation,” Antibiotics, vol. 11, no. 11, p. 1542, Nov. 2022, doi: 10.3390/antibiotics11111542.
10. Y. Shoham, K. Gasteratos, A. J. Singer, Y. Krieger, E. Silberstein, and J. Goverman, “Bromelain-based enzymatic burn debridement: A systematic review of clinical studies on patient safety, efficacy and long-term outcomes,” Dec. 01, 2023, John Wiley and Sons Inc. doi: 10.1111/iwj.14308.
11. S. V. Abhyankar, A. M. Vartak, and G. V. Daftary, “Potential role of systemic enzyme therapy with trypsin, bromelain and rutoside combination in burns,” International Surgery Journal, vol. 8, no. 7, p. 2254, Jun. 2021, doi: 10.18203/2349-2902.isj20212752.
12. S. Brien, G. Lewith, A. Walker, S. M. Hicks, and D. Middleton, “Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies,” Evidence-Based Complementary and Alternative Medicine, vol. 1, no. 3, pp. 251–257, Jan. 2004, doi: 10.1093/ecam/neh035.
13. Z. Marissa, S. R. Mita, C. K. Kusumawulan, and S. Sriwidodo, “Antioxidant and Photoprotective Activity of Bromelain Cream: An In Vitro and In Vivo Study,” Cosmetics, vol. 12, no. 2, Apr. 2025, doi: 10.3390/cosmetics12020041.
14. P. F. Ferreira and R. E. Silva-López, “Plant Therapeutic Proteases: Chemical Aspects, Applications and Pharmaceutical Formulations,” European J Med Plants, pp. 46–63, Nov. 2021, doi: 10.9734/ejmp/2021/v32i1130429.
15. A. Safavinia, S. Dehestani, Z. Salmasi, F. Kalalinia, L. Etemad, and M. Hashemi, “Recent advances in nanocarriers containing Bromelain: In vitro and in vivo studies,” Jul. 01, 2023, Mashhad University of Medical Sciences. doi: 10.22038/NMJ.2022.67975.1724.
16. S. Bayat et al., “Evaluation of debridement effects of bromelain-loaded sodium alginate nanoparticles incorporated into chitosan hydrogel in animal models,” Iran J Basic Med Sci, vol. 24, no. 10, pp. 1404–1412, Oct. 2021, doi: 10.22038/ijbms.2021.58798.13060.
17. Lee Seung-Cheol, Lee Dong-Hoon, Jin Bong-Hwa, and Hwang Yong-Il, “Encapsulation of Bromelain in Liposome,” Prev Nutr Food Sci, vol. 5, pp. 81–85, Jan. 2000.
18. H. Rachmawati, E. Sulastri, M. I. Iwo, D. Safitri, and A. Rahma, “Bromelain encapsulated in self assembly nanoemulsion exhibits better debridement effect in animal model of burned skin,” Journal of Nano Research, vol. 40, pp. 158–166, 2016, doi: 10.4028/www.scientific.net/JNanoR.40.158.
19. A. Rohmah, H. A. Prabowo, S. Setiasih, S. Handayani, M. Jufri, and S. Hudiyono, “The evaluation of activity and stability of isolated bromelain from pineapple cores (Ananas comosus [L.] Merr) and in vitro penetration test of nanoemulsion topical base,” International Journal of Applied Pharmaceutics, vol. 13, no. 5, pp. 336–342, Sep. 2021, doi: 10.22159/ijap.2021v13i5.41769.
20. S. K. H. Gulrez, S. Al-Assaf, and G. O, “Hydrogels: Methods of Preparation, Characterisation and Applications,” in Progress in Molecular and Environmental Bioengineering - From Analysis and Modeling to Technology Applications, InTech, 2011. doi: 10.5772/24553.
21. L. Divya et al., “Evaluation of Formulation Parameters for Bromelain Microspheres Using Pitaya Mucilage Loaded Topical Gel,” Tirupati, Aug. 2020. [Online]. Available: www.ijppr.humanjournals.com
22. D. K. Patel, R. Kesharwani, and V. Kumar, “Etodolac loaded solid lipid nanoparticle based topical gel for enhanced skin delivery,” Biocatal Agric Biotechnol, vol. 29, Oct. 2020, doi: 10.1016/j.bcab.2020.101810.
23. E. Badriyya, Salman, A. R. Pratiwi, D. Dillasamola, Y. Aldi, and E. Husni, “Topical anti-inflammatory activity of bromelain,” Pharmacognosy Journal, vol. 12, no. 6, pp. 1586–1593, Nov. 2020, doi: 10.5530/pj.2020.12.217.
24. J. Prabakar, S. Kumaresan, and P. Kumarr, “In Vitro Evaluation Of Cytotoxicity and Antioxidant Efficacy Of Bromelain,” Int J Dentistry Oral Sci, vol. 08, no. 05, pp. 2516–2519, 2021, [Online]. Available: https://scidoc.org/IJDOS.php
25. Z. Q. Lin Wu et al., “Enzymatic Debridement (Nexobrid) on Burned Hands: Retrospective Review from a Burn Referral Center in Spain,” Plast Reconstr Surg Glob Open, vol. 12, no. 6, Jun. 2024, doi: 10.1097/GOX.0000000000005886.
26. Bhattacharyya Barun K, “Natural Product Radiance Biochemical properties,” kolkata, Jul. 2008.
27. L. Rosenberg, Y. Shoham, B. Berman, S. K. Tyring, M. D. Tharp, and A. J. Singer, “Effective Treatment of Basal Cell Carcinoma with a Topical Enzymatic Mixture Enriched in Bromelain: Summary of Proof-Of Concept Clinical Studies on the First 22 Tumors,” J Clin Med, vol. 13, no. 21, Nov. 2024, doi: 10.3390/jcm13216624.
28. A. N. M. Ramli, T. N. T. Aznan, and R. M. Illias, “Bromelain: from production to commercialisation,” Mar. 30, 2017, John Wiley and Sons Ltd. doi: 10.1002/jsfa.8122.
29. M. G. Holyavka et al., “Novel Biocatalysts Based on Bromelain Immobilized on Functionalized Chitosans and Research on Their Structural Features,” Polymers (Basel), vol. 14, no. 23, Dec. 2022, doi: 10.3390/polym14235110.
30. F. Yu et al., “Dual-Drug Backboned Polyprodrug with a Predefined Drug Combination for Synergistic Chemotherapy,” Nano Lett, vol. 21, no. 5, pp. 2216–2223, Mar. 2021, doi: 10.1021/acs.nanolett.0c05028.
31. R. Pezzani et al., “Anticancer properties of bromelain: State-of-the-art and recent trends,” Jan. 09, 2023, Frontiers Media S.A. doi: 10.3389/fonc.2022.1068778.
32. B. Kwatra, “A REVIEW ON POTENTIAL PROPERTIES AND THERAPEUTIC APPLICATIONS OF BROMELAIN,” www.wjpps.com, vol. 8, p. 488, 2019, doi: 10.20959/wjpps201911-14941.